New Edge Advisors, LLC Biogen Inc. Transaction History

New Edge Advisors, LLC

$13.5 Billion
Q2 2024

A detailed history of New Edge Advisors, LLC transactions in Biogen Inc. stock. As of the latest transaction made, New Edge Advisors, LLC holds 3,013 shares of BIIB stock, worth $589,433. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,013

Previous 3,371 10.62%

Holding current value

$589,433

Previous $726,000 3.86%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	SELL	$190.52 - $236.72 $68,206 - $84,745	-358 Reduced 10.62%	3,013 $698,000
Q1 2024 May 14, 2024	SELL	$212.02 - $267.71 $671,679 - $848,105	-3,168 Reduced 48.45%	3,371 $726,000
Q4 2023 Feb 13, 2024	BUY	$222.59 - $267.94 $706,055 - $849,905	3,172 Added 94.21%	6,539 $1.69 Million
Q3 2023 Nov 14, 2023	BUY	$253.3 - $285.89 $79,536 - $89,769	314 Added 10.28%	3,367 $865,000
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $205,061 - $236,954	745 Added 32.28%	3,053 $869,000
Q1 2023 May 12, 2023	SELL	$256.56 - $292.34 $143,417 - $163,418	-559 Reduced 19.5%	2,308 $641,000
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $446,313 - $542,280	1,768 Added 160.87%	2,867 $793,000
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $1.24 Million - $1.71 Million	-6,359 Reduced 85.26%	1,099 $293,000
Q2 2022 Aug 09, 2022	BUY	$187.54 - $223.02 $1.4 Million - $1.66 Million	7,458 New	7,458 $1.52 Million
Q4 2021 Feb 17, 2022	SELL	$223.92 - $287.77 $269,823 - $346,762	-1,205 Closed	0 $0
Q3 2021 Oct 29, 2021	BUY	$282.99 - $369.05 $341,002 - $444,705	1,205 New	1,205 $341,000
Q4 2020 Jan 27, 2021	SELL	$236.26 - $355.63 $1.1 Million - $1.65 Million	-4,651 Closed	0 $0
Q3 2020 Nov 03, 2020	BUY	$264.77 - $305.71 $42,098 - $48,607	159 Added 3.54%	4,651 $1.32 Million
Q2 2020 Jul 29, 2020	BUY	$258.66 - $342.55 $71,390 - $94,543	276 Added 6.55%	4,492 $1.2 Million
Q1 2020 May 04, 2020	SELL	$268.85 - $341.04 $118,562 - $150,398	-441 Reduced 9.47%	4,216 $1.33 Million
Q4 2019 Jan 31, 2020	SELL	$220.06 - $304.07 $45,992 - $63,550	-209 Reduced 4.3%	4,657 $1.38 Million
Q3 2019 Nov 06, 2019	BUY	$217.44 - $243.88 $1.06 Million - $1.19 Million	4,866 New	4,866 $1.08 Million
Q1 2019 May 09, 2019	SELL	$216.71 - $338.96 $171,200 - $267,778	-790 Closed	0 $0
Q4 2018 Jan 29, 2019	SELL	$278.5 - $352.75 $30,356 - $38,449	-109 Reduced 12.12%	790 $238,000
Q3 2018 Oct 29, 2018	SELL	$293.51 - $383.83 $142,352 - $186,157	-485 Reduced 35.04%	899 $318,000
Q2 2018 Jul 19, 2018	SELL	$257.52 - $306.91 $14,163 - $16,880	-55 Reduced 3.82%	1,384 $409,000
Q1 2018 May 11, 2018	BUY	$260.13 - $367.91 $374,327 - $529,422	1,439 New	1,439 $384,000
Q3 2017 Nov 13, 2017	SELL	$281.15 - $329.69 $149,290 - $175,065	-531 Closed	0 $0
Q2 2017 Aug 16, 2017	BUY	N/A	531	531 $0

Others Institutions Holding BIIB

# of Institutions

1,050

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $28.2B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.

Account

New Edge Advisors, LLC Biogen Inc. Transaction History